NCT01012687已完成不适用
A Single Dose, Two-Period, Two-Treatment, Two-Sequence Crossover Bioequivalency Study of Perindopril Erbumine Tablets 8 mg Under Fasting Conditions
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 48
- 试验地点
- 2
- 主要终点
- bioequivalence determined by statistical comparison Cmax
研究概览
简要总结
The objective of this study was to prove the bioequivalence of Perindopril Erbumine 8 mg tablets under fasting conditions.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening
排除标准
- •Positive test for HIV, Hepatitis B, or Hepatitis C.
- •Treatment with known enzyme altering drugs.
- •History of allergic or adverse response to perindopril or any comparable or similar product.
结局指标
主要结局
bioequivalence determined by statistical comparison Cmax
时间窗: 20 Days
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fed ConditionsEssential HypertensionNCT01013155Roxane Laboratories48
已完成
不适用
Bioequivalency Study of Buprenorphine Hydrochloride 8 mg Tablet Under Fasted ConditionsOpioid-Related DisordersNCT00992095Roxane Laboratories48
已完成
1 期
A Study on the Bioequivalence of Perindopril Tert-butylamine Tablets Taken on After Meals in Healthy SubjectsHealthyNCT04556110Sichuan Haisco Pharmaceutical Group Co., Ltd32
已完成
不适用
Bioequivalency Study of Terbinafine Tablets Under Fasting ConditionsOnychomycosisNCT00602342Roxane Laboratories30
已完成
不适用
Bioequivalency Study of Terbinafine Tablets Under Fed ConditionsOnychomycosisNCT00602251Roxane Laboratories30